Comment on: “Safety of biologic and synthetic targeted therapies in patients with immune-mediated diseases: Data from the BIOBADAGUAY registry” Sarah Aijaz, Raveen Muzaffer

Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients Giovanni Montealegre-Gómez, Edgar Garavito, Arley Gómez-López, Adriana Rojas-Villarraga, Rafael Parra-Medina

Successful use of azathioprine in glucocorticoid refractory immune amegakaryocytic thrombocytopenia of lupus Latika Gupta, Vikas Gupta, Krushna Chandra Pani, Navkirti Mittal, Vikas Agarwal